Satellite Bio launches with new approach to bioengineering tissues
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Moon Velocity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Satellite Bio has emerged from stealth with technology for bioengineering tissue to restore organ function. The regenerative medicine startup, based on research from MIT and Boston University, is backed by $110 million in financing.
Dr. Yaron Daniely of healthcare VC firm aMoon intends to take an active approach to turning academic research into viable companies.